N. Lawrentschuk

N. Lawrentschuk, Richard Archer, A. Scott, 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Pseudoangiomatous hyperplasia of mammary stroma: an unusual entity.

N. Lawrentschuk, Richard Archer, A. Scott, 2003, Hospital medicine.

Modern Active Surveillance in Prostate Cancer: A Narrative Review.

N. Lawrentschuk, D. Murphy, M. Winter*, 2022, Clinical genitourinary cancer.

Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.

A. G. Ellis, N. Lawrentschuk, M. Neely, 2015, The Journal of antimicrobial chemotherapy.

Citation indices for social media articles in urology

H. Woo, N. Lawrentschuk, D. Murphy, 2017, BJU international.

Active involvement of nursing staff in reporting and grading complication‐intervention events—Protocol and results of the CAMUS Pilot Nurse Delphi Study

P. Santaguida, P. Dasgupta, B. Challacombe, 2022, BJUI compass.

Rectourethral fistula following focal irreversible electroporation for prostate cancer

N. Lawrentschuk, S. Ong, Zein Alhamdani, 2022, BMJ Case Reports.

Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue

A. Evans, T. H. van der Kwast, N. Lawrentschuk, 2012, Journal of Clinical Pathology.

Effects of Partial Nephrectomy on Postoperative Blood Pressure

N. Lawrentschuk, G. Trottier, R. Rendon, 2012, Korean journal of urology.

Understanding the role of new systemic agents in the treatment of prostate cancer

N. Lawrentschuk, D. Bolton, A. Joshua, 2016, BJU international.

Adverse impact of malnutrition markers on major abdominopelvic cancer surgery

Mary R. Kwaan, N. Lawrentschuk, D. Murphy, 2019, ANZ journal of surgery.

Testicular Tumor Markers

N. Lawrentschuk, D. Bolton, 2011 .

Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes

A. Tafreshi, N. Lawrentschuk, I. Davis, 2015, ANZ journal of surgery.

Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up

N. Lawrentschuk, J. Lewin, B. Tran, 2022, Cancer Imaging.

The role of 18F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!

N. Lawrentschuk, D. Murphy, T. Akhurst, 2019, Cancer Imaging.

Testicular Sparing Surgery: Is there a Role in Management of Bilateral Orchidectomy?

D. Gillatt, N. Lawrentschuk, D. Bolton, 2016 .

Modern paradigms for prostate cancer detection and management

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2022, The Medical journal of Australia.

Necrotizing fasciitis: an unusual presentation for rectal carcinoma

N. Lawrentschuk, H. Nguyen, A. B. Young, 2003, ANZ journal of surgery.

Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 – what’s old is new again?

N. Lawrentschuk, A. Kamat, J. Teh, 2020, Future oncology.

Bacillus Calmette Gu ´erin (BCG) vaccination use in the fight against COVID-19 – what’s old is new again?

N. Lawrentschuk, A. Kamat, J. Teh, 2020 .

(68)GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITRON EMISSION TOMOGRAPHY (PET) FOR PRIMARY STAGING OF HIGH RISK PROSTATE CANCER: A SYSTEMATIC REVIEW

N. Lawrentschuk, D. Murphy, D. Bolton, 2017 .

Peripheral Primitive Neuroectodermal Tumor Arising from the Seminal Vesicle

N. Lawrentschuk, I. Davis, S. Appu, 2008, Urologia Internationalis.

Myth busting patient's pain: comparing robotic-assisted verses open radical prostatectomies.

N. Lawrentschuk, Benjamin Condon, D. Bagguley, 2020, Gland surgery.

PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer

N. Lawrentschuk, N. Corcoran, K. Sethi, 2022, BMJ Open.

Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil‐to‐lymphocyte ratio in patients with metastatic renal cell carcinoma

P. Gibbs, N. Lawrentschuk, B. Tran, 2016, Internal medicine journal.

Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study

P. Gibbs, N. Lawrentschuk, N. Corcoran, 2022, JMIR cancer.

PSMA-PET guided hook-wire localization of nodal metastases in prostate cancer: a targeted approach

N. Lawrentschuk, C. Duncan, A. Lavoipierre, 2019, World Journal of Urology.

68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2021, World Journal of Urology.

The use of oxidised cellulose as a topical haemostatic dressing on a bleeding stomal wound.

N. Lawrentschuk, P. Hewitt, 2002, Journal of wound care.

Mature and Immature Teratoma: A Review of Pathological Characteristics and Treatment Options

N. Lawrentschuk, D. Bolton, Kiran Manya, 2014 .

Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities

N. Lawrentschuk, A. Azad, G. Rinott Mizrahi, 2022, Current opinion in urology.

Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy

J. Wasiak, N. Lawrentschuk, D. Bolton, 2018, BJU international.

Fluorine-18 Fluorothymidine: A New Positron Emission Radioisotope for Renal Tumors

A. Scott, N. Lawrentschuk, A. Poon, 2006, Clinical nuclear medicine.

Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage

N. Lawrentschuk, D. Bolton, A. Balasubramanian, 2022, World Journal of Urology.

Penile cancer information on the internet: a needle in a haystack

N. Lawrentschuk, C. Duncan, J. Teh, 2018, BJU international.

Prevention of sepsis prior to prostate biopsy

N. Lawrentschuk, D. Bolton, L. Toner, 2016, Investigative and clinical urology.

Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review

N. Lawrentschuk, D. Murphy, A. Azad, 2021, Translational andrology and urology.

Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy.

N. Lawrentschuk, D. Murphy, S. Keam, 2020, European urology focus.

Navigating systemic therapy for metastatic castration-naïve prostate cancer

N. Lawrentschuk, N. Sathianathen, A. Azad, 2020, World Journal of Urology.

Where to Next for Theranostics in Prostate Cancer?

N. Lawrentschuk, D. Murphy, N. Sathianathen, 2019, European urology oncology.

Delivery of intracavernosal therapies using needle-free injection devices

N. Lawrentschuk, D. Bolton, J. D. Plessis, 2017, International Journal of Impotence Research.

Re: Pietro Piazza, Luca Sarchi, Stefano Puliatti, Carlo Andrea Bravi, Sophie Knipper, Alexandre Mottrie. The Unsolved Issue of Reporting of Late Complications in Urology. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.07.010.

N. Lawrentschuk, N. Sathianathen, M. Furrer, 2021, European urology.

Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds

N. Lawrentschuk, D. Bolton, Peter Wong, 2009, Current opinion in urology.

Orthotopic Bladder Substitution (Neobladder) II: Postoperative Complications, Management, and

N. Lawrentschuk, Kevin Ong, 2013 .

Saving Nephrons: Current Surgical Options in Partial Nephrectomy

N. Lawrentschuk, N. Papa, Kiran Manya, 2012 .

Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review

N. Lawrentschuk, D. Murphy, J. O'Brien, 2022, Prostate international.

Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?

N. Lawrentschuk, N. Corcoran, D. Murphy, 2022, BJU international.

Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives

N. Lawrentschuk, L. Qu, 2019, Research and reports in urology.

Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives

N. Lawrentschuk, L. Qu, 2019 .

A Systematic Review of Ileal Conduit and Neobladder Outcomes in Primary Bladder Cancer.

N. Lawrentschuk, D. Hennessey, D. Bolton, 2016, Urology.

In Reply: An example of the evolution of evidence in a new disease.

N. Lawrentschuk, N. Davis, T. Whish-Wilson, 2020, Future oncology.

Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Surgical Perspective

N. Lawrentschuk, D. Murphy, M. Cumberbatch, 2020, The Journal of Nuclear Medicine.

Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19

N. Lawrentschuk, D. Murphy, A. Azad, 2020, Future oncology.

Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer—time for a rethink?

N. Lawrentschuk, D. Bolton, K. Sikaris, 2017, Prostate international.

Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study

P. Gibbs, N. Lawrentschuk, N. Corcoran, 2022, JMIR cancer.

Diabetes and elevated urea level predict for uretero-ileal stricture after radical cystectomy and ileal conduit formation.

N. Lawrentschuk, D. Bolton, S. Sengupta, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Recent developments in the diagnosis and management of N1 penile cancer

N. Lawrentschuk, J. O'Brien, B. Kelly, 2022, Current opinion in urology.

The Role of Lymph Node Fine-Needle Aspiration in Penile Cancer in the Sentinel Node Era

N. Lawrentschuk, D. Bolton, M. Mir, 2011, Advances in urology.

Irreversible Electroporation for Prostate Cancer

N. Lawrentschuk, T. Chengodu, S. Ong, 2021, Life.

Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?

A. G. Ellis, N. Lawrentschuk, D. Bolton, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Renal cell carcinoma with intra-operatively identified encapsulated intra-luminal tumour extension throughout the entire ureter

N. Lawrentschuk, M. Cumberbatch, C. Bishop, 2020 .

Experience and attitudes of final‐year medical students to digital rectal examination

N. Lawrentschuk, D. Bolton, 2004, The Medical journal of Australia.

Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis.

N. Lawrentschuk, D. Murphy, N. Sathianathen, 2022, Urologic oncology.

Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review

H. Woo, N. Lawrentschuk, G. Jack, 2017, Translational andrology and urology.

Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis

N. Lawrentschuk, D. Bolton, A. Bjartell, 2018, World Journal of Urology.

Inserting testicular prostheses: a new surgical technique for difficult cases

D. Webb, N. Lawrentschuk, D. Webb, 2005, BJU international.

Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial.

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2020, European urology.

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

N. Lawrentschuk, P. Stricker, J. Yaxley, 2022, BJU international.

Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short?

N. Lawrentschuk, D. Murphy, V. Kasivisvanathan, 2022, Nature Reviews Urology.

Australasian Colorectal Surgeons in the Modern Era: The Rise of Social Media

N. Lawrentschuk, N. Wickramasinghe, P. Smart, 2018 .

Systematic review: bacterial colonisation of conduits and neobladders—when to test, watch, and treat

N. Lawrentschuk, W. Ranasinghe, A. Adam, 2019, World Journal of Urology.

Vulvar hematoma secondary to spontaneous rupture of the internal iliac artery: clinical review.

N. Lawrentschuk, P. Dundee, E. Egan, 2009, American journal of obstetrics and gynecology.

Renal Artery Aneurysm Causing Symptomatic Hydronephrosis

N. Lawrentschuk, Kiran Manya, D. Ow, 2013 .

Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review

N. Lawrentschuk, D. Bolton, J. Gani, 2005, BJU international.

Recurrent testicular torsion post orchidopexy ‐ an occult emergency: a systematic review

N. Lawrentschuk, A. Adam, A. Laher, 2022, ANZ journal of surgery.

Testicular torsion and the acute scrotum: current emergency management

N. Lawrentschuk, A. Ta, N. Hoag, 2016, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2020, The Lancet.

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Damien Bolton, Nathan Lawrentschuk, Michael S Hofman, 2016, European urology.

Erectile dysfunction: a global review of intracavernosal injectables

N. Lawrentschuk, D. Bolton, C. Duncan, 2019, World Journal of Urology.

Recent advances in magnetic resonance imaging of prostate cancer

U. Lindner, N. Lawrentschuk, 2010, F1000 medicine reports.

Focal therapy in prostate cancer: modalities, findings and future considerations

Nathan Lawrentschuk, John Trachtenberg, Uri Lindner, 2010, Nature Reviews Urology.

Construction and evaluation of an anatomically correct multi-image modality compatible phantom for prostate cancer focal ablation.

R. Weersink, J. Trachtenberg, S. Davidson, 2010, The Journal of urology.

Ureteric stenting 25 years on: routine or risky?

N. Lawrentschuk, J. Russell, 2004, ANZ journal of surgery.

Outcome from percutaneous nephrolithotomy in patients with spinal cord injury, using a single‐stage dilator for access

N. Lawrentschuk, R. Grills, J. Rogerson, 2005, BJU international.

Nephrectomy for a Renal Metastasis of Undiagnosed Hepatocellular Carcinoma Arising From an Orthotopic Liver Transplant Undertaken for Cryptogenic Cirrhosis

N. Lawrentschuk, D. Bolton, D. Gyomber, 2013, Korean journal of urology.

Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.

N. Lawrentschuk, S. Aliyu, S. Al-hayek, 2016, QJM : monthly journal of the Association of Physicians.

Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom

N. Lawrentschuk, S. Aliyu, S. Al-hayek, 2016, Investigative and clinical urology.

Metaplastic conditions of the bladder

N. Lawrentschuk, D. Clouston, 2013, BJU international.

Fine‐needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma

N. Lawrentschuk, D. Bolton, S. Leewansangtong, 2006, BJU international.

Bladder Actinomycosis: Mimicking Tumour

N. Lawrentschuk, D. Bolton, Kiran Manya, 2013 .

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.

N. Lawrentschuk, D. Murphy, D. Bolton, 2020, European urology.

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial.

N. Lawrentschuk, D. Murphy, T. Kron, 2018, European urology.

N. Lawrentschuk, M. Frydenberg, G. Risbridger, 2017 .

Testicular microlithiasis: a case report and review of the literature

N. Lawrentschuk, S. Brough, Rex J. De Ryke, 2003, ANZ journal of surgery.

Organ-sparing approaches for testicular masses

N. Lawrentschuk, M. Jewett, Á. Zúñiga, 2010, Nature Reviews Urology.

Radiographic Diagnosis and Staging

N. Lawrentschuk, M. Santis, D. Bolton, 2011 .

Landmarks in prostate cancer

F. Saad, N. Lawrentschuk, J. Crook, 2018, Nature Reviews Urology.

Prostate cancer biomarkers: Are we hitting the mark?

N. Lawrentschuk, S. Hong, M. Perera, 2016, Prostate international.

The pursuit of the "perfect" biomarker in prostate cancer.

N. Lawrentschuk, 2011, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent models

G. Lockwood, N. Lawrentschuk, A. Toi, 2011, International Urology and Nephrology.

Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.

D. Webb, J. Bedő, D. Agarwal, 2021, European journal of cancer.

Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations

E. Crawford, N. Lawrentschuk, K. Miller, 2018, Prostate Cancer and Prostatic Diseases.

Delineating the anatomy of oncologic postradiation vesicovaginal fistulae with reconstructed computed tomography

N. Lawrentschuk, D. Bolton, G. Koulouris, 2007, International Urogynecology Journal.

Gene expression profiling of localized prostate cancer: getting answers to the questions that really matter.

N. Lawrentschuk, B. Tran, A. Azad, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypoxia and angiogenesis in renal cell carcinoma

N. Lawrentschuk, 2009 .

Looking forward, looking back—10 years in urology

P. Scardino, P. Choyke, W. Linehan, 2014, Nature Reviews Urology.

Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer

N. Lawrentschuk, D. Bolton, M. Alberto, 2023, Cancers.

PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics

M. Cooperberg, N. Lawrentschuk, D. Murphy, 2018, World Journal of Urology.

Prostate cancer screening in Primary Health Care: the current state of affairs

N. Lawrentschuk, D. Pond, M. Frydenberg, 2015, SpringerPlus.

Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study.

N. Lawrentschuk, A. Blanca, A. G. van der Heijden, 2017, Oncotarget.

Tissue-Based Immunohistochemical Markers for Diagnosis and Classification of Renal Cell Carcinoma

N. Lawrentschuk, A. Finelli, D. Bolton, 2020 .

Potential of imaging biomarkers for characterization of renal masses

A. Scott, N. Lawrentschuk, I. Davis, 2010, Expert review of anticancer therapy.

Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens

P. Gibbs, A. Costello, N. Lawrentschuk, 2022, The Prostate.

Re: Olaparib for Metastatic Castration-resistant Prostate Cancer.

N. Lawrentschuk, D. Murphy, M. Cumberbatch, 2020, European urology.

Re: Enzalutamide and Survival in Non-metastatic Castration-resistant Prostate Cancer.

N. Lawrentschuk, D. Murphy, S. Ong, 2020, European urology.

A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol

D. Bailey, N. Lawrentschuk, D. Murphy, 2018, BJU international.

Uro‐oncology multidisciplinary meetings at an Australian tertiary referral centre – impact on clinical decision‐making and implications for patient inclusion

N. Lawrentschuk, D. Bolton, A. Azad, 2014, BJU international.

Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer

N. Lawrentschuk, D. Murphy, M. Hofman, 2022 .

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.

H. Woo, N. Lawrentschuk, D. Murphy, 2021, European urology.

Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for me

H. Woo, N. Lawrentschuk, D. Murphy, 2020 .

68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends

N. Lawrentschuk, D. Murphy, S. Siva, 2017, Prostate international.

68 Ga-prostate-speci fi c membrane antigen-positron emission tomography / computed tomography in advanced prostate cancer : Current state and future trends

N. Lawrentschuk, D. Murphy, S. Siva, 2017 .

Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence.

N. Lawrentschuk, N. Fleshner, K. Fernandes, 2011, The Journal of urology.

Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer—A Prospective Cohort Study

N. Lawrentschuk, D. Murphy, P. Bowden, 2022, Cancers.

Current role of multiparametric magnetic resonance imaging in the management of prostate cancer

N. Lawrentschuk, D. Bolton, P. Katelaris, 2015, Korean journal of urology.

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer.

N. Lawrentschuk, D. Murphy, M. Perera, 2018, JAMA oncology.

Updates of prostate cancer staging: Prostate-specific membrane antigen

N. Lawrentschuk, D. Murphy, N. Sathianathen, 2016, Investigative and clinical urology.

Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.

H. G. van der Poel, P. Dasgupta, A. Mottrie, 2021, Urologic oncology.

Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches.

H. G. van der Poel, P. Dasgupta, A. Mottrie, 2019, The Journal of urology.

Clinical significance of the positive surgical margin based upon location, grade, and stage.

A. Evans, A. Zlotta, N. Lawrentschuk, 2010, Urologic oncology.

Prostate‐specific membrane antigen‐positron emission tomography/computed tomography (PSMA‐PET/CT)‐guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single‐institution experience and review of the published literature

V. Khoo, N. Lawrentschuk, D. Bolton, 2019, BJU international.

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial.

S. Loi, N. Lawrentschuk, D. Murphy, 2021, European urology.

Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer

N. Lawrentschuk, D. Murphy, D. Moon, 2022, BJU international.

Cribriform pattern disease over‐represented in pelvic lymph node metastases identified on 68GA PSMA‐PET/CT

N. Lawrentschuk, D. Bolton, C. Duncan, 2022, BJUI compass.

The role of PSMA PET/CT imaging in the diagnosis, staging and restaging of prostate cancer.

N. Lawrentschuk, D. Murphy, M. Hofman, 2021, Future oncology.

Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer

N. Lawrentschuk, D. Bolton, S. Sengupta, 2018, Nature Reviews Urology.

Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer

N. Lawrentschuk, C. Higano, L. Klotz, 2020, Nature Reviews Urology.

Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study.

Neil Fleshner, Nathan Lawrentschuk, David Margel, 2012, The Journal of urology.

Proximal seminal vesicle displacement and margins for prostate cancer radiotherapy

V. Khoo, N. Lawrentschuk, F. Foroudi, 2021, Journal of medical radiation sciences.

Declining use of radical prostatectomy and pelvic lymphadenectomy despite more robotics: National population data over 15 years

N. Lawrentschuk, J. Yaxley, D. Bolton, 2020, Asia-Pacific journal of clinical oncology.

Risk stratification and avoiding overtreatment in localized prostate cancer.

N. Lawrentschuk, W. Ranasinghe, Bishoy Hanna, 2019, Current opinion in urology.

Active surveillance for low-risk prostate cancer: an update

N. Lawrentschuk, L. Klotz, 2011, Nature Reviews Urology.

Diagnosis of bone metastases in urological malignancies--an update.

N. Lawrentschuk, D. Bolton, N. Rajarubendra, 2010, Urology.

Acute urinary retention and the difficult catheterization: current emergency management

N. Lawrentschuk, R. Sultana, A. Sliwinski, 2016, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial

V. Khoo, N. Lawrentschuk, D. Bolton, 2018, World Journal of Urology.

Peritoneal "pillowcase" for the displaced spleen post-distal pancreatectomy.

N. Lawrentschuk, S. Appu, A. B. Young, 2005, Journal of hepato-biliary-pancreatic surgery.

Suprapubic stab cystostomy: a safer technique.

N. Lawrentschuk, P. Marriott, Dominic Lee, 2003, Urology.

Orthotopic bladder substitution (neobladder): part I: indications, patient selection, preoperative education, and counseling.

N. Lawrentschuk, L. Johnson, Kevin Ong, 2013, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.

Exploring pathways towards improving patient experience of robot‐assisted radical prostatectomy (RARP): assessing patient satisfaction and attitudes

N. Lawrentschuk, D. Bolton, C. Bulsara, 2018, BJU international.

Orthotopic Bladder Substitution (Neobladder): Part II Postoperative Complications, Management, and Long-term Follow-up

N. Lawrentschuk, L. Johnson, Kevin Ong, 2013, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.

Urology trial success – get urologists involved early

N. Lawrentschuk, 2019, BJU international.

Self‐reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population‐based registry

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2021, Psycho-oncology.

Miniaturised percutaneous nephrolithotomy versus flexible ureteropyeloscopy: a systematic review and meta-analysis comparing clinical efficacy and safety profile

N. Lawrentschuk, D. Bolton, C. Poyet, 2018, World Journal of Urology.

Robotic Assisted Radical Cystectomy vs Open Radical Cystectomy: Systematic Review and Meta-Analysis

D. Parekh, N. Lawrentschuk, M. Frydenberg, 2019, The Journal of urology.

Supervisor volume affects oncological outcomes of trainees performing open radical prostatectomy

G. Giles, N. Lawrentschuk, D. Bolton, 2016, ANZ journal of surgery.

Same day discharge for robot‐assisted radical prostatectomy: a prospective cohort study documenting an Australian approach

A. Costello, N. Lawrentschuk, N. Corcoran, 2023, ANZ journal of surgery.

Thoracic Surgery Information on the Internet: A Multilingual Quality Assessment

Nathan Lawrentschuk, Myles Davaris, N. Lawrentschuk, 2017, Interactive journal of medical research.

Renal colic: current protocols for emergency presentations

D. Webb, N. Lawrentschuk, D. Bolton, 2016, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Radical cystectomy and orthotopic bladder substitution: surgical tricks and management of complications.

N. Lawrentschuk, D. Bolton, L. Izquierdo, 2013, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineation.

V. Khoo, N. Lawrentschuk, F. Foroudi, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Carbon Footprint in Flexible Ureteroscopy: A Comparative Study on the Environmental Impact of Reusable and Single-Use Ureteroscopes.

N. Lawrentschuk, D. Bolton, G. Jack, 2018, Journal of endourology.

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

V. Khoo, N. Lawrentschuk, N. Hardcastle, 2018, BMC Cancer.

Laparoscopic lens fogging: a review of etiology and methods to maintain a clear visual field.

Nathan Lawrentschuk, N. Lawrentschuk, N. Fleshner, 2010, Journal of endourology.

Future directions in advanced penile cancer - mechanisms of carcinogenesis and a search for targeted therapy.

N. Lawrentschuk, R. Ramsay, A. Heriot, 2020, Future oncology.

Staphylococcus aureus urinary tract bacteriuria: single-institutional antibiotic susceptibility trends over a decade

N. Lawrentschuk, S. Aliyu, S. Al-hayek, 2017, Bladder.

Functional imaging of renal cell carcinoma

A. Scott, N. Lawrentschuk, I. Davis, 2010, Nature Reviews Urology.

Assessing regional hypoxia in human renal tumours using 18F‐fluoromisonidazole positron emission tomography

Nathan Lawrentschuk, A. Scott, N. Lawrentschuk, 2005, BJU international.

Prostate cancer immunology – an update for Urologists

N. Lawrentschuk, L. Klotz, I. Davis, 2011, BJU international.

The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma.

R. Hannan, N. Lawrentschuk, S. Lo, 2022, European urology.

A Systematic Review of Intra- and Postoperative Complication Reporting and Grading in Urological Surgery: Understanding the Pitfalls and a Path Forward.

N. Lawrentschuk, N. Sathianathen, B. Thomas, 2023, European urology oncology.

68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review

N. Lawrentschuk, D. Bolton, M. Perera, 2018, World Journal of Urology.

Prostate‐specific membrane antigen for the surgical oncologist: interpreting expression beyond the prostate

N. Lawrentschuk, D. Bolton, M. Farag, 2020, ANZ journal of surgery.

Small renal mass: what the urologist needs to know for treatment planning and assessment of treatment results.

N. Lawrentschuk, M. Jewett, O. Stakhovskyi, 2011, AJR. American journal of roentgenology.

Cytoreductive surgery for men with metastatic prostate cancer

N. Lawrentschuk, D. Murphy, D. Moon, 2015, Prostate international.

Urethral squamous cell carcinoma presenting as a Fourniere’s Gangrene

N. Lawrentschuk, S. Warrier, A. Chauhan, 2017 .

Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy

N. Lawrentschuk, D. Bolton, R. Persad, 2017, Prostate international.

Population‐based analysis of prostate‐specific antigen (PSA) screening in younger men (<55 years) in Australia

N. Lawrentschuk, D. Bolton, R. Persad, 2014, BJU international.

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

N. Lawrentschuk, M. Frydenberg, P. Stricker, 2013, BJU international.

PET in prostate and bladder tumors.

A. Scott, N. Lawrentschuk, S. Lee, 2012, Seminars in nuclear medicine.

Prevention and management of TURP-related hemorrhage

N. Lawrentschuk, G. Jack, L. Kavanagh, 2011, Nature Reviews Urology.

Multi-resistant Escherichia coli sepsis following transrectal ultrasound-guided prostate biopsy.

D. Webb, N. Lawrentschuk, I. Jennens, 2006, British journal of hospital medicine.

Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review

N. Lawrentschuk, S. Shariat, P. Karakiewicz, 2017, World Journal of Urology.

Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study.

N. Lawrentschuk, N. Sathianathen, B. Konety, 2018, Urologic oncology.

Thursday 13 October 2016

N. Lawrentschuk, M. Lukies, N. Papa, 2016, Journal of medical imaging and radiation oncology.

Visual Occlusion During Minimally Invasive Surgery: A Contemporary Review of Methods to Reduce Laparoscopic and Robotic Lens Fogging and Other Sources of Optical Loss.

N. Lawrentschuk, D. Bolton, M. Perera, 2017, Journal of endourology.

CAUDA EQUINA SYNDROME SECONDARY TO CONSTIPATION: AN UNCOMMON OCCURRENCE

N. Lawrentschuk, H. Nguyen, 2005, ANZ journal of surgery.

Anterior prostatectomy for the excision of bladder paraganglioma with prostatic invasion: a unique case of partial prostatectomy

N. Lawrentschuk, A. Lamb, O. Prall, 2020, ANZ journal of surgery.

Surgical Management of Pheochromocytoma in a Contemporary Setting

N. Lawrentschuk, J. Serpell, S. Grodski, 2013 .

Cancer in Lockdown: Impact of the COVID‐19 Pandemic on Patients with Cancer

Daswin De Silva, N. Lawrentschuk, D. Bolton, 2020, The oncologist.

Improving informed consent for patients undergoing radical prostatectomy using multimedia techniques: a prospective randomized crossover study

N. Lawrentschuk, D. Bolton, D. Gyomber, 2010, BJU international.

Inguinal lymph node dissection for penile cancer: a contemporary review

N. Lawrentschuk, C. Duncan, J. Teh, 2019, Translational andrology and urology.

Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.

S. Berlangieri, A. Scott, N. Lawrentschuk, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

An update on focal therapy for prostate cancer

U. Lindner, N. Lawrentschuk, M. Perera, 2016, Nature Reviews Urology.

Low‐grade prostate cancer should still be labelled cancer

B. Delahunt, D. Berney, D. Bostwick, 2022, BJU international.

Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand

N. Lawrentschuk, D. Murphy, S. Mark, 2022, BJU international.

Detection and localisation of primary prostate cancer using 68 Ga-PSMA PET/CT compared with mpMRI and radical prostatectomy specimens.

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2019, BJU international.

Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.

N. Lawrentschuk, R. O’Sullivan, Shannon McGrath, 2018, Urology.

The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review

Nathan Lawrentschuk, Hashim U. Ahmed, Rodolfo Montironi, 2014, European urology.

Risk of developing prostate cancer in the future: overview of prognostic biomarkers.

N. Lawrentschuk, N. Fleshner, 2009, Urology.

Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound‐guided biopsy: the Victorian Transperineal Biopsy Collaboration experience

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2015, BJU International.

Transperineal biopsy of the prostate—is this the future?

Nathan Lawrentschuk, B. Challacombe, N. Lawrentschuk, 2013, Nature Reviews Urology.

Understanding the diagnosis of prostate cancer

N. Lawrentschuk, D. Murphy, J. Yaxley, 2020, The Medical journal of Australia.

Detection and localisation of primary prostate cancer using 68gallium prostate‐specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2020, BJU international.

Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2014, BJU international.

– Prostate Cancer The Role of Focal Therapy in the Management of Localised Prostate Cancer : A Systematic Review

J. Trachtenberg, N. Lawrentschuk, H. Ahmed, 2014 .

Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis

N. Lawrentschuk, N. Sathianathen, D. Bolton, 2018, Prostate Cancer and Prostatic Diseases.

Diagnosis of bone metastases in urological malignancies—an update

N. Lawrentschuk, S. Ong, D. Bagguley, 2022, Bone Cancer.

Chapter 45 – Diagnosis of bone metastases in urological malignancies – an update

N. Lawrentschuk, D. Bolton, N. Rajarubendra, 2015 .

Imaging of Bone Metastases

N. Lawrentschuk, N. Rajarubendra, 2010 .

Management of men with previous negative prostate biopsy

N. Lawrentschuk, A. Finelli, M. Perera, 2016, Current opinion in urology.

Magnetic resonance imaging cognitive fusion biopsy – is near enough good enough?

N. Lawrentschuk, N. Sathianathen, B. Konety, 2018, BJU international.

Dressing size and pain: A prospective trial

N. Lawrentschuk, C. Campbell, P. Hewitt, 2003, ANZ journal of surgery.

Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: first reported case of yet another mask

N. Lawrentschuk, D. Clouston, D. Christidis, 2018, BMJ Case Reports.

Implications of amyloidosis on prostatic biopsy

N. Lawrentschuk, D. Bolton, R. Stillwell, 2004, International journal of urology : official journal of the Japanese Urological Association.

Open partial nephrectomy: current review

N. Lawrentschuk, J. Ischia, B. Timm, 2020, Translational andrology and urology.

Strategies for success: a multi‐institutional study on robot‐assisted partial nephrectomy for complex renal lesions

N. Lawrentschuk, D. Hennessey, D. Bolton, 2018, BJU international.

Occult renal segmental arterial injury after trauma.

N. Lawrentschuk, D. Bolton, 2005, Urology.

Guideline of guidelines: follow‐up after nephrectomy for renal cell carcinoma

N. Lawrentschuk, Timothy J. Williamson, D. Bolton, 2016, BJU international.

Efficacy of the novel, innovative, single‐use grasper integrated flexible cystoscope for ureteral stent removal: a systematic review

N. Lawrentschuk, A. Adam, A. Bhattu, 2021, ANZ journal of surgery.

Trans‐urethral snare stent removal: a novel, self‐constructed innovation for simultaneous ureteral stent removal and safety guidewire insertion

N. Lawrentschuk, A. Adam, A. Bhattu, 2021, ANZ journal of surgery.

Fournier's gangrene - delayed pedicle flap based upon the anterior abdominal wall.

N. Lawrentschuk, D. Bolton, A. Sliwinski, 2014, International braz j urol : official journal of the Brazilian Society of Urology.

Creation and validation of a visual macroscopic hematuria scale for optimal communication and an objective hematuria index.

N. Lawrentschuk, Douglas G Travis, L. Wong, 2010, The Journal of urology.

Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy

D Bolton, N. Lawrentschuk, D. Bolton, 2018, World Journal of Urology.

Current management of radiation cystitis: a review and practical guide to clinical management

N. Lawrentschuk, D. Murphy, B. Lamb, 2018, BJU international.

Use of holmium laser for removal of an intraluminal ureteric suture

N. Lawrentschuk, D. Bolton, J. Rogerson, 2004, International journal of urology : official journal of the Japanese Urological Association.

Complication reporting and grading: consensus with the Complication Reporting after minor and major Urological Surgery (CAMUS) collaboration

N. Lawrentschuk, 2021, BJU international.

Long‐term oncological outcomes of the Agarwal loop‐ligation technique for management of the distal ureter during laparoscopic radical nephroureterectomy

D. Agarwal, N. Lawrentschuk, Grace Florescu, 2020, BJU international.

Bladder cancer surveillance in patients with spinal cord injuries

N. Lawrentschuk, L. Qu, 2018, BJU international.

Robot-assisted ipsilateral ureteroureterostomy in a duplex system utilizing intraoperative flexible ureteroscopy

N. Lawrentschuk, J. Teh, E. O’Connor, 2020, Urology case reports.

Health information quality on the internet in urological oncology: a multilingual longitudinal evaluation.

Nathan Lawrentschuk, N. Lawrentschuk, N. Fleshner, 2009, Urology.

The role of cystectomy in elderly patients – a multicentre analysis

N. Lawrentschuk, D. Bolton, M. Rouprêt, 2015, BJU international.

18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.

A. Scott, N. Lawrentschuk, I. Davis, 2014, Urology.

Laparoscopic lens fogging: solving a common surgical problem in standard and robotic laparoscopes via a scientific model

N. Lawrentschuk, D. Bolton, N. Papa, 2018, Surgical Endoscopy.

Ureteral intramural metastatic deposit of prostate cancer with ureteric obstruction

N. Lawrentschuk, D. Wetherell, T. Manning, 2018, BMJ Case Reports.

Incidence of Bladder Cancer in Sri Lanka: Analysis of the Cancer Registry Data and Review of the Incidence of Bladder Cancer in the South Asian Population

N. Lawrentschuk, D. Bolton, Daswin de Silva, 2012, Korean journal of urology.

Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome

N. Lawrentschuk, S. Matin, M. Rouprêt, 2018, Bladder cancer.

Precise application of fibrin glue into a fistula between the rectal stump and urinary bladder – a new technique

J. Stanley, N. Lawrentschuk, J. Ooi, 2008 .

The social media revolution is changing the conference experience: analytics and trends from eight international meetings

Nathan Lawrentschuk, N. Lawrentschuk, D. Murphy, 2015, BJU international.

Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial

N. Lawrentschuk, D. Murphy, T. Kron, 2017, BJU international.

Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship.

N. Lawrentschuk, T. Kron, S. Siva, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Fiducial markers and spacers in prostate radiotherapy: current applications

N. Lawrentschuk, R. Chee, M. Ng, 2014, BJU international.

Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment

N. Lawrentschuk, P. Stricker, James E. Thompson, 2019, BJU international.

Globalization of Continuing Professional Development by Journal Clubs via Microblogging: A Systematic Review

Damien Bolton, Nathan Lawrentschuk, N. Lawrentschuk, 2015, Journal of medical Internet research.

The emerging use of Twitter by urological journals

Nathan Lawrentschuk, Gregory J Nason, N. Lawrentschuk, 2015, BJU international.

Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score.

N. Lawrentschuk, D. Murphy, N. Sathianathen, 2019, European urology focus.

Online and social media presence of Australian and New Zealand urologists

H. Woo, N. Lawrentschuk, D. Murphy, 2015, BJU international.

Clinical fellows: valuable or not? Opinions of Australian and New Zealand urology trainees and consultants

N. Lawrentschuk, D. Hennessey, R. Grills, 2016, ANZ journal of surgery.

Knowledge of smoking as a risk factor for disease among urology clinic patients in Australia

N. Lawrentschuk, N. Papa, T. Nzenza, 2018, World Journal of Urology.

Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer

D. Webb, A. Costello, N. Lawrentschuk, 2020 .

Use of PSMA PET/CT in Response Assessment Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer.

D. Webb, A. Costello, N. Lawrentschuk, 2020, BJU International.

ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY: IMPLICATIONS OF PROLONGED WAITING TIMES FOR SURGERY

N. Lawrentschuk, P. Hewitt, Michael Pritchard, 2003, ANZ journal of surgery.

Robotic multivisceral pelvic resection: experience from an exenteration unit

N. Lawrentschuk, D. Murphy, A. Heriot, 2020, Techniques in Coloproctology.

Continuous bladder irrigation after transurethral resection of non‐muscle invasive bladder cancer for prevention of tumour recurrence: a systematic review

N. Lawrentschuk, I. Davis, S. Sengupta, 2021, ANZ journal of surgery.

Polyorchidism: a case report and review of the literature

N. Lawrentschuk, R. MacGregor, 2004, ANZ journal of surgery.

Long-term outcomes of external sphincterotomy in a spinal injured population.

N. Lawrentschuk, D. Bolton, A. Troy, 2009, The Journal of urology.

An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy

N. Lawrentschuk, D. Ranson, D. Bolton, 2006, BJU international.

Incidence and risk factors of venous thromboembolism after pelvic uro‐oncologic surgery – a single center experience

N. Lawrentschuk, D. Bolton, S. Sengupta, 2016, BJU international.

Prostate‐specific antigen testing testing in the modern era

N. Lawrentschuk, D. Bolton, S. Ong, 2022, ANZ journal of surgery.

Imaging renal cell carcinoma with ultrasonography, CT and MRI

N. Lawrentschuk, A. Finelli, M. Leveridge, 2010, Nature Reviews Urology.

A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer

N. Lawrentschuk, D. Bolton, M. Perera, 2020, World Journal of Urology.

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort

Nathan Lawrentschuk, Theodorus H van der Kwast, Antonio Finelli, 2011, BJU international.

Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: a large North American experience.

N. Lawrentschuk, M. Jewett, Á. Zúñiga, 2011, The Journal of urology.

Therapeutic options following orchiectomy for stage I seminoma.

N. Lawrentschuk, N. Fleshner, 2009, Oncology.

Clinical stage I seminoma: the case for surveillance

N. Lawrentschuk, N. Fleshner, 2009, World Journal of Urology.

Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years

N. Lawrentschuk, D. Bolton, M. Perera, 2015, Prostate international.

Adjuvant Systemic Treatment for Renal Cancer After Surgery: A Network Meta-Analysis

N. Lawrentschuk, D. Murphy, N. Sathianathen, 2022, Société Internationale d’Urologie Journal.

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

N. Lawrentschuk, D. Murphy, S. Siva, 2023, Contemporary clinical trials communications.

Quality of Health Information on the Internet for Prostate Cancer

N. Lawrentschuk, R. Abouassaly, D. Chang, 2018, Advances in urology.

Systemic therapy in metastatic hormone-sensitive prostate cancer

N. Lawrentschuk, D. Murphy, A. Azad, 2022, Current opinion in supportive and palliative care.

Benign Prostate Disorders

N. Lawrentschuk, M. Perera, 2016 .

Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer.

T. H. van der Kwast, J. Trachtenberg, N. Lawrentschuk, 2011, The Journal of urology.

A Whole of Population, Multiuser Series of High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: Outcomes and Implications.

H. Woo, G. Giles, G. Severi, 2015, Journal of endourology.

Centralisation of complex urological surgery and understanding the three Es: is it inevitable?

N. Lawrentschuk, 2021, BJU international.

Telehealth, virtual meetings and conferences in urology: ‘good’ COVID side effects

N. Lawrentschuk, 2021, BJU International.

Time for bi‐national quality audits for Australian and New Zealand urology

N. Lawrentschuk, 2014, BJU International.

Salvage irreversible electroporation for radio‐recurrent prostate cancer – the prospective FIRE trial

N. Lawrentschuk, P. Stricker, W. Delprado, 2022, BJU international.

Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution

N. Lawrentschuk, A. Ryan, J. Grummet, 2021, Translational andrology and urology.

Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer.

N. Lawrentschuk, M. Hofman, A. R. Ravi Kumar, 2020, Current opinion in urology.

Urological outcomes in Australia and New Zealand: who's watching?

N. Lawrentschuk, 2017, BJU international.

COVID‐19 and urology in Australia and New Zealand: uncertain times

N. Lawrentschuk, 2020, BJU international.

Role of surgery in high-risk localized prostate cancer.

A. Zlotta, N. Lawrentschuk, C. Kuk, 2010, Current oncology.

Biomaterials and Regenerative Medicine in Urology.

M. Walsh, N. Lawrentschuk, D. Bolton, 2018, Advances in experimental medicine and biology.

Renal Cell Carcinoma Follow-Up - Is it Time to Abandon Ultrasound?

N. Lawrentschuk, D. Bolton, C. Poyet, 2019, Current Urology.

Patterns of care for metastatic renal cell carcinoma in Australia

P. Gibbs, N. Lawrentschuk, B. Tran, 2015, BJU international.

Health on the Net: Do Website Searches Return Reliable Health Information on Hemorrhoids and Their Treatment?

Nathan Lawrentschuk, N. Lawrentschuk, Matthew Wen Long Ng, 2017 .

Female urinary incontinence health information quality on the Internet: a multilingual evaluation

N. Lawrentschuk, D. Bolton, I. Saraswat, 2015, International Urogynecology Journal.

Transperineal prostate biopsy – tips for analgesia

N. Lawrentschuk, D. Bolton, M. Perera, 2017, BJU international.

Evolution of technologies in urology: full steam ahead?

N. Lawrentschuk, 2018, World journal of urology.

Correspondence from specialist surgical outpatient clinics to general practitioners

N. Lawrentschuk, D. Bolton, S. Sengupta, 2018, ANZ journal of surgery.

The impact of the global bacille Calmette–Guérin shortage on treatment patterns: population‐based data

N. Lawrentschuk, D. Bolton, M. Roberts, 2018, BJU international.

Trends in the surgical treatment of benign prostatic hyperplasia in a tertiary hospital

N. Lawrentschuk, S. Clarke, D. Bolton, 2018, ANZ journal of surgery.

Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma

N. Lawrentschuk, D. Bolton, S. Sengupta, 2017, Investigative and clinical urology.

Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors.

L. Kiemeney, H. Moch, N. Lawrentschuk, 2023, European urology.

Personalized Medicine in Urologic Oncology

Y. Lotan, N. Lawrentschuk, J. Schalken, 2020 .

Urological Society of Australia and New Zealand's alignment with the BJU International: a collaborative success magnified by a supplement journal

N. Lawrentschuk, D. Bolton, D. Nicol, 2014, BJU international.

Robotic-assisted vs. open radical prostatectomy: A machine learning framework for intelligent analysis of patient-reported outcomes from online cancer support groups.

Damminda Alahakoon, Damien Bolton, Raj Persad, 2018, Urologic oncology.

Patterns‐of‐care and health economic analysis of robot‐assisted radical prostatectomy in the Australian public health system

A. Costello, N. Lawrentschuk, D. Murphy, 2016, BJU international.

A smoking cessation program as a resource for bladder cancer patients.

N. Lawrentschuk, K. Hersey, N. Fleshner, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Radical prostatectomy in obese patients: Improved surgical outcomes in recent years

J. Trachtenberg, U. Lindner, N. Lawrentschuk, 2010, International journal of urology : official journal of the Japanese Urological Association.

Alvimopan for post-radical cystectomy ileus: what should we know?

N. Lawrentschuk, C. Duncan, J. Teh, 2019, Translational andrology and urology.

An Investigation of the Basic Physics of Irrigation in Urology and the Role of Automated Pump Irrigation in Cystoscopy

N. Lawrentschuk, R. Manecksha, D. Chang, 2012, TheScientificWorldJournal.

Single‐use disposable digital flexible ureteroscopes: an ex vivo assessment and cost analysis

N. Lawrentschuk, D. Hennessey, D. Bolton, 2018, BJU international.

Utility of lymphadenectomy following cystectomy for non-urothelial bladder cancer: a systematic review.

N. Lawrentschuk, J. Crozier, Stephanie Demkiw, 2016, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Changing practice of pelvic lymph node dissection in management of primary bladder cancer.

N. Lawrentschuk, D. Bolton, S. Sengupta, 2016, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

The role of radical cystectomy in patients with unresectable or regionally metastatic urothelial carcinoma of the bladder

N. Lawrentschuk, A. Kamat, S. Delacroix, 2015 .

A unique urine isolating drape technique for on table pyeloscopy post radical cystectomy for a suspected upper tract lesion with an obliterated ureteric orifice.

N. Lawrentschuk, S. Ong, D. Woon, 2022, Urology.

Current Role of PET, CT, MR for Invasive Bladder Cancer

A. Scott, N. Lawrentschuk, S. Lee, 2013, Current Urology Reports.

Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery: Commentary on: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study.

N. Lawrentschuk, H. Zargar, K. Zargar-Shoshtari, 2017, Urology.

Watchful Waiting in Advanced Prostate Cancer

N. Lawrentschuk, M. Mir, 2013 .

Primary transitional cell carcinoma of penis – A rare presentation

N. Lawrentschuk, J. Teh, P. Kearns, 2018, Urology case reports.

Quality of handwritten surgical operative notes from surgical trainees: a noteworthy issue

N. Lawrentschuk, D. Bolton, S. Sengupta, 2019, ANZ journal of surgery.

Survival outcomes in elderly men undergoing radical prostatectomy in Australia

N. Lawrentschuk, D. Bolton, R. Persad, 2018, ANZ journal of surgery.

Pain relief after triamcinolone infiltration in patients with bladder pain syndrome with Hunner’s ulcers

N. Lawrentschuk, A. Alcaraz, L. Izquierdo, 2017, International Urogynecology Journal.

Predicting the risk of positive surgical margins following robotic-assisted radical prostatectomy.

N. Lawrentschuk, D. Murphy, D. R. Alchin, 2017, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

H. Woo, N. Lawrentschuk, D. Murphy, 2020, BJU international.

Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.

N. Lawrentschuk, D. Moon, Jianliang Liu, 2023, European urology.

Brachytherapy: state‐of‐the‐art radiotherapy in prostate cancer

Nathan Lawrentschuk, P. Grimm, N. Lawrentschuk, 2015, BJU international.

Following the Trend: A Comparative Analysis of Public Engagement and Funding for Annual Prostate and Breast Cancer Campaigns Using Google Trends

N. Lawrentschuk, James R M Colbourne, J. Toniolo, 2022, Anticancer Research.

CATCH-22: a manual bladder washout protocol to improve care for clot retention

N. Lawrentschuk, Shannon McGrath, D. Christidis, 2018, World Journal of Urology.

Exploratory models comparing ethiodized oil-glue and gold fiducials for bladder radiotherapy image-guidance

V. Khoo, N. Lawrentschuk, Rachel O’Meara, 2021, Physics and imaging in radiation oncology.

Risk factors for Gleason Score upgrading following radical prostatectomy.

N. Lawrentschuk, D. Murphy, D. R. Alchin, 2016, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections

D. Neal, J. Shamash, N. Lawrentschuk, 2021, World Journal of Urology.

Bladder cancer: working towards better outcomes.

N. Lawrentschuk, 2016, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Operator is an independent predictor of detecting prostate cancer at transrectal ultrasound guided prostate biopsy.

A. Evans, G. Lockwood, N. Lawrentschuk, 2009, The Journal of urology.

Reply to Fabio Zattoni, Filiberto Zattoni, and Laura Evangelista's Letter to the Editor re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A S

N. Lawrentschuk, D. Bolton, M. Hofman, 2017, European Urology.

Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer.

A. Evans, T. H. van der Kwast, J. Trachtenberg, 2011, European urology.

Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study

Damien Bolton, Nathan Lawrentschuk, Graham G. Giles, 2017, Cancer Causes & Control.

US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?

Haidar Al Saffar, N. Lawrentschuk, J. O'Brien, 2023, European urology open science.

Is There an Optimal Curative Option in HIV-Positive Men with Localized Prostate Cancer? A Systematic Review

N. Lawrentschuk, D. Bolton, A. Adam, 2019, Current Urology.

Men’s health on the web: an analysis of current resources

N. Lawrentschuk, D. Bolton, J. Teh, 2019, World Journal of Urology.

Critical appraisal of meta-analyses: an introductory guide for the practicing surgeon

N. Lawrentschuk, U. Güller, J. McCall, 2009, Patient safety in surgery.

Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study.

D. English, G. Giles, G. Severi, 2017, Urologic oncology.

Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis.

Han Jie Lee, N. Lawrentschuk, Y. Takwoingi, 2023, European urology.

1739P Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: Analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502)

N. Lawrentschuk, B. Tran, I. Davis, 2022, Annals of Oncology.

Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: A planned interim analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502).

N. Lawrentschuk, I. Davis, P. Grimison, 2020 .

Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.

T. D. de Reijke, J. Chin, E. Crawford, 2023, European urology.

CUAJ – Case Series O’Connor et al Peritoneal and port-site metastasis after RARP

N. Lawrentschuk, D. Murphy, D. Bolton, 2020 .

Case series – Peritoneal and port-site metastasis following robotic-assisted radical prostatectomy

N. Lawrentschuk, D. Murphy, D. Bolton, 2020 .

New Approaches to Targeting Epigenetic Regulation in Bladder Cancer

N. Lawrentschuk, D. Bolton, D'a. W. Thompson, 2023, Cancers.

Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.

N. Lawrentschuk, K. Hersey, N. Fleshner, 2010, The Journal of urology.

A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes

N. Lawrentschuk, D. Bolton, D. L. Joon, 2018, Journal of contemporary brachytherapy.

Focal laser ablation for localized prostate cancer.

Nathan Lawrentschuk, John Trachtenberg, Uri Lindner, 2010, Journal of endourology.

Case of the Month from Peter MacCallum Cancer Centre, Melbourne, Australia: ICG‐assisted robotic Boari flap ureteric reimplantation in a case of missed ureteric injury

N. Lawrentschuk, Kenneth Chen, 2022, BJU international.

690 NERVE-SPARING RADICAL PROSTATECTOMY IN SELECTED HIGH-RISK AND LOCALLY ADVANCED PROSTATE CANCERS IS ASSOCIATED WITH LOW POSITIVE MARGIN RATES USING A COMBINATION OF PREOPERATIVE MRI, SPECIAL INSTRUMENTATION AND INTRA-OPERATIVE FROZEN SECTIONS

A. Evans, N. Lawrentschuk, P. Boström, 2010 .

Fellowships: more not less to improve employability and patient outcomes

N. Lawrentschuk, 2015, BJU international.

Poster Award, 1st Prize: An analysis of the new single use felxible ureteroscope: comparison with reusable flexible ureteroscope. Which is best?

Derek B. Hennessey, Grzegorz Fojecki, Nathan Lawrentschuk, 2016 .

Wound blisters post hip surgery: A prospective trial comparingdressings

N. Lawrentschuk, M. Pirpiris, M. Falkenberg, 2002, ANZ journal of surgery.

R OLE OF CYTOREDUCTIVE PROSTATECTOMY IN NON-ORGAN CONFINED PROSTATE CANCER

N. Lawrentschuk, D. Murphy, N. Sathianathen, 2015 .

Sclerosing Lipogranuloma of the Genitalia Treated with Corticosteroids

N. Lawrentschuk, D. Bolton, D. Angus, 2005, International Urology and Nephrology.

TRANSPERINEAL VERSUS TRANSRECTAL BIOPSY FOR RADICAL PROSTATECTOMY SPECIMENS 785

N. Lawrentschuk, 2012 .

Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial.

S. Loi, N. Lawrentschuk, D. Murphy, 2021 .

Assessment of Intrafraction Motion of the Urinary Bladder Using Magnetic Resonance Imaging (cineMRI).

N. Lawrentschuk, T. Kron, D. L. Joon, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classification To Describe the Surgical Difficulty for Renal Masses for Which Robotic Partial Nephrectomy Is Planned

Scott Van Appledorn, D. Agarwal, N. Lawrentschuk, 2023, European urology open science.

Is it worth to perform radical prostatectomy in a salvage setting? Results of a contemporary multicentre series of 395 cases

P. Dasgupta, A. Mottrie, D. Gillatt, 2018 .

Trends in percutaneous renal biopsy: The evolving diagnostic pathway for the small renal mass

N. Lawrentschuk, D. Bolton, N. Papa, 2018, Urology annals.

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

N. Lawrentschuk, D. Murphy, B. Tran, 2022, European urology open science.

P007 Transperineal biopsy prostate cancer detection in first biopsy and post-negative TRUS biopsy settings: The Victorian transperineal biopsy collaboration experience

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2014 .

Investigating PSMA-PET/CT to resolve prostate MRI PIRADS4-5 and negative biopsy discordance

N. Lawrentschuk, N. Corcoran, D. Bolton, 2023, World Journal of Urology.

Renal cell carcinoma: imaging and therapy

Nathan Lawrentschuk, N. Lawrentschuk, D. Bolton, 2007, Current opinion in urology.

Robotic-assisted radical prostatectomy: learning curves and outcomes from an Australian perspective

N. Lawrentschuk, J. O'Brien, D. Murphy, 2022, Prostate international.

A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy

V. Khoo, N. Lawrentschuk, F. Foroudi, 2023, Frontiers in Oncology.

Metastatic Breast Cancer to the Bladder

N. Lawrentschuk, D. Bolton, Y. Chan, 2005, The breast journal.

A systematic review and meta-analysis of the long-term outcomes of ileal conduit and orthotopic neobladder urinary diversion.

N. Lawrentschuk, N. Davis, E. Browne, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports

N. Lawrentschuk, A. Adam, A. Laher, 2023, BJU international.

Spontaneous renal calyceal and ureteric rupture secondary to intravenous contrast during computed tomography intravenous pyelogram

N. Lawrentschuk, D. Hennessey, T. Nzenza, 2016, BMJ Case Reports.

Renal track creation for percutaneous nephrolithotomy: the history and relevance of single stage dilation.

D. Webb, N. Lawrentschuk, R. Manecksha, 2015, The Canadian journal of urology.

A marriage of inconvenience

N. Lawrentschuk, D. James, D Ong Hii, 2005, Medical Journal of Australia.

Primary bacterial pyomyositis associated with septic arthritis caused by Streptococcus pyogenes: a case report.

N. Lawrentschuk, M. Pirpiris, M. Falkenberg, 2003, American journal of orthopedics.

Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under‐reported malignancy

N. Lawrentschuk, C. Oldmeadow, J. Attia, 2013, BJU international.

Fixed Drug Eruption of the Penis Secondary to Sulfamethoxazole-Trimethoprim

N. Lawrentschuk, A. Troy, David Pan, 2006, TheScientificWorldJournal.

ADVANCES IN THE IMAGING OF THE PROSTATE IN THE SETTING OF ELEVATED PSA LEVELS

N. Lawrentschuk, D. Murphy, R. Hicks, 2015 .

Decade‐long trends in prostate cancer biopsy grade groups and treatment within a population‐based registry

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2023, BJU international.

Immediate Adjuvant Radiation Therapy Following Radical Prostatectomy Should Not Be Advised for Men with Extraprostatic Extension Who Have Negative Surgical Margins.

P. Walsh, N. Lawrentschuk, 2016, European urology.

Should follow-up biopsies for men on active surveillance for prostate cancer be restricted to limited templates?

J. Trachtenberg, N. Lawrentschuk, A. Toi, 2013, Urology.

Metachronous metastasis to the penis from carcinoma of the rectum

N. Lawrentschuk, S. Appu, J. Russell, 2006, International journal of urology : official journal of the Japanese Urological Association.

Primary care follow-up of radical prostatectomy patients: A regional New Zealand experience

N. Lawrentschuk, M. Perera, T. Manning, 2016, Prostate international.

Active surveillance in intermediate risk prostate cancer: is it safe?

N. Lawrentschuk, Nishanth Krishnananthan, 2016, International braz j urol : official journal of the Brazilian Society of Urology.

‘Prostate Cancer' Information on the Internet: Fact or Fiction?

N. Lawrentschuk, A. Adam, M. Perera, 2020, Current Urology.

39 A sterile disposable sheath system for flexible cystoscopes

N. Lawrentschuk, D. Bolton, M. Chamberlain, 2006 .

Sterile disposable sheath system for flexible cystoscopes.

N. Lawrentschuk, M. Chamberlain, 2005, Urology.

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

V. Khoo, N. Lawrentschuk, N. Hardcastle, 2018, BMC Cancer.

Continuous bladder irrigation after transurethral resection of non‐muscle invasive bladder cancer for prevention of tumour recurrence: a systematic review

N. Lawrentschuk, I. Davis, S. Sengupta, 2020, ANZ journal of surgery.

Editorial Comment.

N. Lawrentschuk, 2019, Journal of Urology.

Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue

A. Evans, T. H. van der Kwast, N. Lawrentschuk, 2012, Journal of Clinical Pathology.

The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review

J. Trachtenberg, N. Lawrentschuk, H. Ahmed, 2014, European urology.

Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2014, BJU international.

The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory.

N. Lawrentschuk, D. Murphy, N. Sathianathen, 2017, Future oncology.

PSMA FOR THE SURGICAL ONCOLOGIST: INTERPRETING EXPRESSION BEYOND THE PROSTATE

N. Lawrentschuk, M. Farag, Damien M Bolton, 2019 .

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial.

N. Lawrentschuk, D. Murphy, T. Kron, 2018, European urology.

Evolution and Implications of the Novel CAMUS Reporting and Classification System: From Rationale to End Product

P. Dasgupta, N. Lawrentschuk, B. Thomas, 2023, European urology open science.

Comparing the Diagnostic Performance of Micro-Ultrasound-Guided Biopsy Versus Multiparametric Magnetic Resonance Imaging-Targeted Biopsy in the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-Analysis

N. Lawrentschuk, N. Sathianathen, S. Perera, 2022 .

Short circuit

N. Lawrentschuk, P. Kearns, 2004 .

N. Lawrentschuk, D. Bolton, D. Gyomber, 2022 .

Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: a large North American experience.

N. Lawrentschuk, M. Jewett, Á. Zúñiga, 2011, The Journal of urology.

Carbon Footprint in Flexible Ureteroscopy: A Comparative Study on the Environmental Impact of Reusable and Single-Use Ureteroscopes.

N. Lawrentschuk, D. Bolton, G. Jack, 2018, Journal of endourology.

Thoracic Surgery Information on the Internet: A Multilingual Quality Assessment

N. Lawrentschuk, R. Abouassaly, Myles T Davaris, 2017, Interactive journal of medical research.

Bringing clarity or confusion? The role of prostate‐specific membrane antigen positron‐emission/computed tomography for primary staging in prostate cancer

N. Lawrentschuk, D. Murphy, M. Hofman, 2017, BJU international.

Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy.

N. Lawrentschuk, B. Thomas, Jianliang Liu, 2023, European urology.

Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study.

N. Lawrentschuk, P. Jackson, S. Sandhu, 2023, European urology.

Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis

N. Lawrentschuk, N. Sathianathen, D. Bolton, 2018, Prostate Cancer and Prostatic Diseases.

Health information quality on the internet in urological oncology: a multilingual longitudinal evaluation.

N. Lawrentschuk, N. Fleshner, R. Abouassaly, 2009, Urology.

Online urological educational material for medical students: can search engines be trusted?

N. Lawrentschuk, S. Ong, Ray Swann, 2021, BJU international.

Quality of Health Information on the Internet for Prostate Cancer

N. Lawrentschuk, R. Abouassaly, D. Chang, 2018, Advances in urology.

Quality of Health Information on the Internet for Urolithiasis on the Google Search Engine

N. Lawrentschuk, R. Abouassaly, D. Chang, 2016, Advances in urology.

A multilingual evaluation of current health information on the Internet for the treatments of benign prostatic hyperplasia

N. Lawrentschuk, D. Bolton, R. Manecksha, 2014, Prostate international.

Fiducial markers and spacers in prostate radiotherapy: current applications

N. Lawrentschuk, R. Chee, M. Ng, 2014, BJU international.

Patterns‐of‐care and health economic analysis of robot‐assisted radical prostatectomy in the Australian public health system

A. Costello, N. Lawrentschuk, D. Murphy, 2016, BJU international.

Gleason pattern 4: active surveillance no more

N. Lawrentschuk, D. Murphy, N. Sathianathen, 2016, BJU international.

Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds

N. Lawrentschuk, D. Bolton, Peter Wong, 2009, Current opinion in urology.

Renal Cell Carcinoma Following Testicular Cancer: Case Report and Literature Review

N. Lawrentschuk, D. Bolton, D. Gyomber, 2005, International Urology and Nephrology.

Contemporary Accuracy of Digital Abdominal X-Ray for Follow-Up of Pure Calcium Urolithiasis: Is There Still a Role?

N. Lawrentschuk, D. Bolton, N. Papa, 2016, Journal of endourology.

Cost Effectiveness of Systemic Treatment Intensification for Metastatic Hormone-sensitive Prostate Cancer: Is Triplet Therapy Cost Effective?

N. Lawrentschuk, N. Sathianathen, Damien Bolton, 2023, European urology oncology.

Patterns of care for metastatic renal cell carcinoma in Australia

P. Gibbs, N. Lawrentschuk, B. Tran, 2015, BJU international.

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET

S. Berlangieri, A. Scott, N. Lawrentschuk, 2014, Asia Oceania journal of nuclear medicine & biology.

Lessons learned: end‐user assessment of a skills laboratory based training programme for urology trainees

N. Lawrentschuk, N. Corcoran, R. Grills, 2011, BJU international.

The Career Medical Interview: solid selector or just ‘impression management’?

N. Lawrentschuk, D. Bolton, Ray Swann, 2015, BJU international.

Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register

Damien Bolton, Nathan Lawrentschuk, Gianluca Severi, 2014, Australian and New Zealand journal of public health.